Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Thrombosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Thrombosis
    Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review - (JAMA)
    Value of Genetic Testing for Preventing Blood Clots Unproven, Study Shows - (DGNews)
    Rivaroxaban More Effective Than Enoxaparin in Reducing Symptomatic Thrombotic Events in Patients Undergoing Total Hip or Knee Replacement: Presented at EHA - (DGDispatch)
    Use of MRI Increases Efficacy of Thrombolysis in Acute Stroke Beyond the 3.5-Hour Time Window: Presented at ESC - (DGDispatch)
    Thigh-Length Graduated Compression Stockings Do Not Significantly Prevent Thromboembolism After Stroke: Presented at ESC - (DGDispatch)

    News archive

     Recent webcasts/CME - Thrombosis
      Keys to Successful Outcomes from Anticoagulant and Antiplatelet Therapy: Addressing Medication Therapy Management Issues
      Thrombotic Thrombocytopenic Purpura: The Masquerader
      Cardiovascular Series: Guidelines for Anticoagulant Therapy in the Prevention and Treatment of Venous Thromboembolism: Achieving Meaningful Quality Improvement
      Perioperative Management Strategies for the Patient Requiring Warfarin
      VTE and the Hospital Pharmacist: Implementing Optimal Management Protocols

      Webcasts/CME archive

       Recent cases - Thrombosis
        Clopidogrel Resistance "Live" - The Risk of Stent Thrombosis Should Be Evaluated Before Procedures
        Stent Angioplasty of Narrowed Portocaval Shunt in Budd Chiari Syndrome: A Case Report
        Refractory Thrombotic Thrombocytopenic Purpura Associated with Oral Contraceptives and Factor V Leiden: A Case Report
        Contrast Echocardiography for the Evaluation of Tumors and Thrombi
        Hybrid Epicardial and Endocardial Catheter Ablation in a Patient With Atrial Fibrillation and Suspicious Left Atrial Thrombus

        Cases archive
          




        my personal edition > thrombosis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Rapid D-Dimer Methods Comparable To ELISA For Detecting Deep Vein Thrombosis

        Blood Coagulation and Fibrinolysis

        09/19/2003
        By Emma Hitt, PhD


        Rapid D-dimers assays appear to be highly sensitive for detecting deep vein thrombosis (DVT), according to new research.

        Enzyme-linked immunosorbent assay (ELISA), currently the gold standard for detecting DVT, requires specialised equipment, technical expertise, and 2 to 3 hours to perform. In contrast, newer methods for measuring D-dimers, based on ELISA and immunoturbidometry, allow diagnosis in less than 1 hour, and require only limited technical expertise.

        To compare these newer methods with ELISA, Robert C. Gosselin, MD, with the University of California Davis Medical Center, Sacramento, United States, and colleagues evaluated 151 patients suspected of DVT.

        A whole blood D-dimer test (SimpliRED, Agen) was performed, and then tested using enzyme-linked immunosorbent assay (VIDAS D-Dimer, BioMerieux; Asserachrome D-Di, Stago International; Dimertest Gold, Agen) and automated immunoturbidometric methods (Advanced D-Dimer, Dade Behring; MiniQuant, Biopool). The researchers then compared each D-dimer method with radiographic results to determine sensitivity and negative predictive value (NPV).

        Of the patients, 23.2% had a positive Doppler ultrasound, with 26 proximal, 8 distal thromboses. One patient had both proximal and distal thromboses. Two patients were excluded due to inconclusive results.

        Overall, the sensitivities for the rapid D-dimer methods were: SimpliRED, 82.3%; VIDAS D-Dimer, 91.4%; MiniQuant D-Dimer, 96.3%; and Advanced D-Dimer, 97.1%.

        In the inpatient only population, the sensitivity was increased: SimpliRED (86.4%), VIDAS D-Dimer (95.5%), MiniQuant D-Dimer (100%), and Advanced D-Dimer (100%).

        "The VIDAS D-Dimer, MiniQuant D-Dimer, and Advanced D-Dimer all demonstrate high sensitivity and NPV in patients suspected of DVT," the researchers conclude. "All D-dimer methods compared favourably with the more traditional ELISA methods, yet have the advantage of being quicker and easier to run," they add.

        According to the researchers, these D-dimer methods could be safely substituted for ELISA tests as part of the DVT work-up. However, the SimpliRED whole-blood method was only moderately sensitive and "therefore must be used in conjunction with probability estimates and other radiographic studies to be of clinical value," they note.

        "Further clinical management studies are necessary to determine the thrombotic risk in patients with negative Advanced D-dimer and Mini-Quant D-dimer results to assure that these tests can safely exclude DVT in symptomatic patients," they suggest.


        Blood Coagul Fibrinolysis 2003;14:545-550.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send